Gainers:
JDA Software Group Inc. (JDAS) is surging 17 percent to $44.79. RedPrairie has agreed to buy the company through a cash tender offer for $45 per share. The transaction has a total enterprise value of around $1.9 billion.
Macy's, Inc. (M) is rising nearly 4 percent to $39.50. The company's October same store sales improved 4.1 percent, with total sales climbing 3.6 percent. The company also raised its same store sales growth outlook for the second half of 2012 to around 4 percent.
Decliners:
Exxon Mobil Corp. (XOM) is down 0.73 percent to $90.50. The company's third quarter earnings declined from the year-ago quarter. Upstream earnings fell from the previous year period. Quarterly total revenues and other income declined from the last year comparable quarter, but were above the consensus estimate.
Pfizer Inc. (PFE) is down 2 percent to $24.38. The company's third quarter profit declined from the same period previous year. Reported revenues fell 16 percent. The company lowered its full-year adjusted earnings per share and revenue guidance. Meanwhile, the company announced a new $10 billion share repurchase program.
Avon Products, Inc. (AVP) is falling 2 percent to $15.19. The company's third quarter profit plunged from the previous year period. Total revenue for the quarter declined from the year-ago quarter and was below the consensus estimate. Terming the quarterly results as disappointing, the company lowered its quarterly dividend.
Teradata Corp. (TDC) is down 8 percent to $63.00. Despite increasing year-over-year, the company's revenue was sharply below the consensus estimate. The company's earnings rose from the year-ago period. Teradata also announced that it currently expects full-year revenue growth at the low end of its prior guidance range.
Target Corp. (TGT) is down nearly 2 percent to $62.70. The company's October comparable store sales growth was 2.4 percent, near the low end of its expected range.
Abiomed, Inc. (ABMD) is plunging 19 percent to $16. The company disclosed that on October 26, 2012, it was informed that the U.S. Attorney's Office for the District of Columbia is conducting an investigation focused on its marketing and labeling of the Impella 2.5. The company has received a subpoena yesterday related to this investigation. Meanwhile, the company reported higher second profits and revenues from the year-ago period.
Trading halt:
Trading in shares of IRIS International Inc. (IRIS) was halted. Danaher Corp. (DHR) announced the successful completion of the tender offer for the company. As a result of the tender offer, Danaher owned about 91.6 percent of outstanding shares, which allowed Danaher to complete and close the merger on October 31, 2012, without stockholder approval.
For comments and feedback: editorial@rttnews.com